## **Core Concept**
Hypertrophic cardiomyopathy (HCM) is a condition characterized by the thickening of the heart muscle (myocardium) that can lead to obstruction of blood flow and increased risk of sudden cardiac death. It is often associated with genetic mutations affecting sarcomeric proteins. The pathophysiology involves abnormal myocardial hypertrophy, myofiber disarray, and interstitial fibrosis.

## **Why the Correct Answer is Right**
The correct answer, ., implies that option D is the statement that is NOT true regarding hypertrophic cardiomyopathy. To accurately assess this, each option must be evaluated against known facts about HCM.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without the specific details of option A, we cannot directly address its accuracy. However, if option A states a recognized feature of HCM, such as asymmetric septal hypertrophy, it would be correct.
- **Option B:** Similarly, if option B describes a common characteristic of HCM, like the presence of a systolic murmur due to left ventricular outflow tract obstruction, it would be a true statement.
- **Option C:** If option C mentions a typical ECG finding in HCM, such as left ventricular hypertrophy or abnormal Q waves, it would also be accurate.

## **Option D Analysis:**
- **Option D:** This option is stated as the correct answer, implying it contains an incorrect statement about HCM. Common misconceptions or incorrect statements might include claims that HCM is primarily caused by hypertension, that it always leads to heart failure, or that it is uniformly associated with a poor prognosis. HCM can indeed lead to heart failure symptoms and increased risk of sudden death, but its prognosis varies widely among individuals.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **hypertrophic cardiomyopathy is a leading cause of sudden cardiac death in young athletes**. Its diagnosis often involves a combination of echocardiography showing significant left ventricular hypertrophy and genetic testing for pathogenic sarcomeric gene mutations. A critical clinical correlation is that **patients with HCM should avoid competitive sports and high-intensity exertion** to minimize the risk of sudden death.

## **Correct Answer: D.**